STOCK TITAN

Insider sale notice: 1,376 shares by RCKT insider (NASDAQ: RCKT)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

RCKT filing of a Form 144 reports proposed sale of 1,376 common shares tied to restricted stock vesting dated 02/13/2026. The filing also records prior sales by the reporting person: 1,646 shares on 11/18/2025 and 12,253 shares on 02/13/2026.

Positive

  • None.

Negative

  • None.

Insights

Form 144 lists a proposed sale of 1,376 vested restricted shares and two recent disposals.

The filing shows 1,376 common shares to be sold on 02/13/2026 reported as "Restricted Stock Vesting" with the issuer noted as the source of shares. This indicates the shares became transferable upon vesting.

Prior transactions recorded are 1,646 shares sold on 11/18/2025 and 12,253 shares sold on 02/13/2026. Cash‑flow treatment and purchaser details are not provided in the excerpt; subsequent filings may disclose settlement specifics.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the RCKT Form 144 report?

It reports a proposed sale of 1,376 common shares tied to restricted stock vesting on 02/13/2026. The filing also lists prior disposals of 1,646 and 12,253 shares on 11/18/2025 and 02/13/2026 respectively.

Who is the reporting person on the RCKT Form 144?

The excerpt identifies Martin Wilson with an address in Cranbury, NJ as a reporting person. The entry lists his past sales and the current proposed sale tied to restricted stock vesting.

How many shares were sold by the reporting person in the past three months?

The filing shows recent sales totaling 12,253 shares on 02/13/2026 and 1,646 shares on 11/18/2025. These are recorded under 'Securities Sold During The Past 3 Months.'

What is the nature of the shares proposed for sale in the RCKT filing?

The proposed 1,376 common shares are described as resulting from Restricted Stock Vesting on 02/13/2026. The filing lists the issuer as the source of the vested shares.

Does the Form 144 disclose proceeds or purchasers for the RCKT sale?

The provided excerpt does not disclose purchase counterparties or proceeds. The entry lists share counts and dates but omits cash‑flow details and purchaser identities.
Rocket Pharmaceu

NASDAQ:RCKT

RCKT Rankings

RCKT Latest News

RCKT Latest SEC Filings

RCKT Stock Data

404.75M
104.02M
Biotechnology
Pharmaceutical Preparations
Link
United States
NEW YORK